• Home
  • Stock
  • Bliss GVS Pharma Fundamental Analysis
  • Bliss GVS Pharma Fundamental Analysis

Bliss GVS Pharma fundamental analysis

BLISSGVS

HealthcareSmall

167.76

0.89 (0.53%)
Last updated on 6 Dec, 2025 | 14:05 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Bliss GVS Pharma Fundamentals

P/E Ratio

16.5

P/B Ratio

1.6

Div. Yield

0.29

Sector P/E

36.18

Sector P/B

0.98

Sec. Div. Yield

0.56

  • Bliss GVS Pharma Fundamentals is currently trading with a P/E Ratio of 16.5, compared to the sector average of 36.18. Its P/B Ratio stands at 1.6, while the sector’s is 0.98. In terms of returns, the stock offers a Dividend Yield of 0.29%, which is than the sector’s 0.56%.

Bliss GVS Pharma Score Card

  • Price

    Attractive

  • Growth

    Average

  • Quality

    Good

  • Management

    Average

  • On its scorecard, Bliss GVS Pharma reflects: Price – Attractive, Growth – Average, Quality – Good, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.